Efficacy and Safety of TACE Combined With Sorafenib Plus Immune Checkpoint Inhibitors for the Treatment of Intermediate and Advanced TACE-Refractory Hepatocellular Carcinoma: A Retrospective StudyLiyun Zheng, Jiansong Ji, Minjiang Chen et al.|Frontiers in Molecular Biosciences|2021Cited by 90